EXPLAINER: Why Elizabeth Holmes’ trial hinges on intent
The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup’s blood-testing technology to rip off investors while … Read More
![]()

